Sensus Healthcare, Inc. (SRTS)

Market Cap	146.52M
Revenue (ttm)	41.31M
Net Income (ttm)	9.31M
Shares Out	16.39M
EPS (ttm)	0.57
PE Ratio	15.71
Forward PE	17.64
Dividend	n/a
Ex-Dividend Date	n/a

Volume	459,453
Open	8.31
Previous Close	8.37
Day's Range	8.31 - 9.20
52-Week Range	2.05 - 9.20
Beta	1.04
Analysts	Strong Buy
Price Target	12.50 (+39.82%)
Earnings Date	Nov 14, 2024

About SRTS

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which pr...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jun 3, 2016
• Employees: 35
• Stock Exchange: NASDAQ
• Ticker Symbol: SRTS
• Website: https://sensushealthcare.com

Financial Performance

In 2023, Sensus Healthcare's revenue was $24.41 million, a decrease of -45.20% compared to the previous year's $44.53 million. Earnings were $485,000, a decrease of -98.00%.

Analyst Forecast

According to 2 analysts, the average rating for SRTS stock is "Strong Buy." The 12-month stock price forecast is $12.5, which is an increase of 39.82% from the latest price.

Price Target

$12.5

(39.82% upside)

Analyst Consensus: Strong Buy